UroGen Pharma Ltd. (URGN) insider trading.
In Q3 2026, insiders at UroGen Pharma Ltd. reported 7 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $3.4M.
- Transactions
- 7
- Purchases (P)
- 0
- Sales (S)
- 4
- Net shares, P minus S
- -73,067
- Insiders
- 3
- Last filed
- 2026-09-09
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Schoenberg Mark | Officer · Chief Medical Officer | 4 | 0 | 3 |
| Smith Jason Drew | Officer · General Counsel | 2 | 0 | 1 |
| Robinson James A. Jr. | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | Smith Jason Drew | S (D) | 1,519 | $42.54 | 53,141 | Form 4 |
| 2026-09-08 | Schoenberg Mark | S (D) | 871 | $42.92 | 59,882 | Form 4 |
| 2026-09-07 | Smith Jason Drew | M (A) | 3,334 | — | 54,660 | Form 4 |
| 2026-09-07 | Schoenberg Mark | M (A) | 1,667 | — | 60,753 | Form 4 |
| 2026-08-26 | Robinson James A. Jr. | M (A) | 2,000 | — | 8,000 | Form 4 |
| 2026-08-20 | Schoenberg Mark | S (D) | 60,677 | $47.05 | 59,086 | Form 4 |
| 2026-07-09 | Schoenberg Mark | S (D) | 10,000 | $40 | 119,763 | Form 4 |
Transaction codes in this quarter
Get URGN insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1668243&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · URGN company page · UroGen Pharma Ltd. on SEC.gov
Questions
Are insiders buying or selling UroGen Pharma Ltd. (URGN)?
In Q3 2026, insiders at UroGen Pharma Ltd. reported 7 non-derivative transactions on 5 Forms 3, 4 and 5: 0 open-market purchases and 4 sales worth $3.4M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these UroGen Pharma Ltd. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/urgn.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.